Paloma Partners’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-17,700
| Closed | -$51K | – | 1832 |
|
|
2019
Q3 | $51K | Buy |
+17,700
| New | +$51K | ﹤0.01% | 1546 |
|
|
2019
Q2 | – | Sell |
-13,774
| Closed | -$112K | – | 1469 |
|
|
2019
Q1 | $112K | Buy |
13,774
+3,376
| +32% | +$27.5K | ﹤0.01% | 1255 |
|
|
2018
Q4 | $84K | Buy |
+10,398
| New | +$84K | ﹤0.01% | 885 |
|
|
2018
Q3 | – | Sell |
-30,300
| Closed | -$174K | – | 1236 |
|
|
2018
Q2 | $174K | Buy |
+30,300
| New | +$174K | ﹤0.01% | 1165 |
|
|
2017
Q4 | – | Sell |
-10,328
| Closed | -$54K | – | 1271 |
|
|
2017
Q3 | $54K | Buy |
+10,328
| New | +$54K | ﹤0.01% | 1447 |
|
|
2015
Q4 | – | Sell |
-14,482
| Closed | -$165K | – | 1361 |
|
|
2015
Q3 | $165K | Sell |
14,482
-33,018
| -70% | -$376K | ﹤0.01% | 1164 |
|
|
2015
Q2 | $709K | Buy |
+47,500
| New | +$709K | 0.01% | 731 |
|
|
2013
Q3 | – | Sell |
-229,064
| Closed | -$355K | – | 908 |
|
|
2013
Q2 | $355K | Buy |
+229,064
| New | +$355K | 0.02% | 576 |
|